Global Vaccines Market Size study, By Type (Conjugate vaccines, Inactivated and subunit vaccines, Live attenuated vaccines, Recombinant vaccines, Toxoid vaccines), By Technology (Monovalent vaccines, Multivalent vaccines), By Disease Indication (Pneumococ

Global Vaccines Market Size study, By Type (Conjugate vaccines, Inactivated and subunit vaccines, Live attenuated vaccines, Recombinant vaccines, Toxoid vaccines), By Technology (Monovalent vaccines, Multivalent vaccines), By Disease Indication (Pneumococcal disease, DTP, Influenza, HPV, Meningococcal disease, Polio, Rotavirus, Hepatitis, MMR, Varicella, Herpes zoster, Other disease indications), By Route of Administration (Intramuscular and subcutaneous administration, Oral administration, Other routes of administration), By Patient Type (Pediatric patients, Adult patients), and Regional Forecasts 2022-2028

Global Vaccines Market is valued at approximately USD 47.74 billion in 2021and is anticipated to grow with a healthy growth rate of more than 7.0% over the forecast period 2022-2028. A vaccine is a biological product that offers vigorous acquired immunity to a specific infectious disease. A vaccine is used to boost the creation of antibodies and deliver immunity against one or several diseases. It comprises an agent that mimics a disease-causing microorganism and is usually produced from a debilitated or killed form of the microbe, its toxins, or one of its surface proteins. The growing occurrence of emerging and re-emerging infectious diseases, rising focus on immunization programs, increasing government support for vaccine development, and rising industry initiatives to augment vaccine R&D activities are the chief factors that may surge the market demand across the globe. For instance, as per the UNICEF, in November 2019, about 260,000 vaccination doses were delivered to prevent measles in Tonga, Samoa, and Fiji. However, the high cost of vaccine development impedes the growth of the market over the forecast period of 2022-2028. Also, the rising inclination on therapeutic vaccines is anticipated to act as a catalyzing factor for the market demand during the forecast period.

The key regions considered for the global Vaccines market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to growing investments by the various non-government and government organizations for vaccine development and the high prevalence of infectious diseases. Whereas, Asia-Pacific is also anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as rising government initiatives, growing healthcare expenditure, and the presence of a large patient population would create lucrative growth prospects for the Vaccines market across the Asia-Pacific region.

Major market players included in this report are:
GlaxoSmithKline plc
Pfizer, Inc.
Sanofi Pasteur
Merck & Co., Inc.
CSL Limited
Emergent BioSolutions, Inc.
Johnson & Johnson
Serum Institute of India Pvt. Ltd.
Mitsubishi Tanabe Pharma Corporation
Panacea Biotec

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Type offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
Conjugate vaccines
Inactivated and subunit vaccines
Live attenuated vaccines
Recombinant vaccines
Toxoid vaccines
By Technology:
Monovalent vaccines
Multivalent vaccines
By Disease Indication:
Pneumococcal disease
DTP
Influenza
HPV
Meningococcal disease
Polio
Rotavirus
Hepatitis
MMR
Varicella
Herpes zoster
Other disease indications
By Route of Administration:
Intramuscular and subcutaneous administration
Oral administration
Other routes of administration
By Patient Type:
Pediatric patients
Adult patients
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Vaccines Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors


Companies Mentioned

GlaxoSmithKline plc
Pfizer, Inc.
Sanofi Pasteur
Merck & Co., Inc.
CSL Limited
Emergent BioSolutions, Inc.
Johnson & Johnson
Serum Institute of India Pvt. Ltd.
Mitsubishi Tanabe Pharma Corporation
Panacea Biotec Show more